Long-Term Effects of a Diabetes Disease Management Program on Quality of Care and Costs: A Staggered Difference-in-Differences Analysis

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background & Aim : Evidence on long-term effectiveness of diabetes disease management programs (DMPs) remains limited, with mixed findings on sustainability and cost-effectiveness. This study evaluates the long-term impact of a comprehensive DMP on quality of care and healthcare costs over six years (2018–2023). The DMP was implemented in 17 Swiss primary care practices and featured guideline-based individualized treatment plans, continuous process evaluation, interprofessional collaboration, and quality circles. We assessed the program's impact on guideline-adherent diabetes care, hospitalization, and healthcare costs over six years (2018–2023). Methods : A staggered difference-in-differences (DiD) design analyzed claims data from 2,813 patients in 17 DMP practices (treatment group) and 17,906 patients receiving usual care (control group). Outcomes included guideline-adherent diabetes care (HbA₁c monitoring, lipid profiling, nephropathy assessment, ophthalmological examination), hospitalization, and healthcare costs. The staggered DiD approach accounted for variations in implementation timing and controlled for patient- and year-fixed effects. Results : Patients in DMP practices showed a sustained 6 to 11 percentage point improvement in guideline-adherent diabetes care (95% CI for the fifth follow-up year: 8 to 14 percentage points) compared to controls. Hospitalization rates did not differ significantly between groups (95% CI for the fifth year: -0.05 to 0.00). Healthcare cost growth was significantly lower in the DMP group in years three (95% CI: CHF -2353 to -879), four (95% CI: CHF -3023 to -1419), and five (95% CI: CHF -2942 to -796), representing average cost savings exceeding 10% of total healthcare costs per patient. Conclusion : The DMP led to sustained improvements in guideline-adherent diabetes care and reduced healthcare cost growth over six years. The staggered DiD design provides robust evidence across diverse settings and implementation timelines, addressing key gaps in long-term DMP effectiveness research. These findings support broader implementation of structured DMPs for improving quality and efficiency of diabetes care in primary care settings. JEL Classification: I10, I18

Article activity feed